Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – McVicar Website

Daniel W. McVicar, Ph.D.

Selected Publications

1)  Sen SK, Boelte KC, Barb JJ, Joehanes R, Zhao X, Cheng Q, Adams L, Teer JK, Accame DS, Chowdhury S, Singh LN, Kavousi M, Peyser PA, Quigley L, Priel DL, Lau K, Kuhns DB, Yoshimura T, Johnson AD, Hwang SJ, Chen MY, Arai AE, Green ED, Mullikin JC, Kolodgie FD, O'Donnell CJ, Virmani R, Munson PJ, McVicar DW, Biesecker LG.
Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification.
Am. J. Hum. Genet. 95: 66-76, 2014.
[Journal]
2)  O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW.
Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
J. Immunol. 192: 2875-84, 2014.
[Journal]
3)  Montalvo V, Quigley L, Vistica BP, Boelte KC, Nugent LF, Takai T, McVicar DW, Gery I.
Environmental Factors Determine DAP12 Deficiency To Either Enhance or Suppress Immunopathogenic Processes.
Immunology. 2013.
[Journal]
4)  Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW.
LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-? production by repressing ß-catenin activation in dendritic cells.
PLoS Pathog. 9: e1003357, 2013.
[Journal]
5)  O'Connor GM, Basatena NS, Olavarria V, Macnamara A, Vine A, Ying Q, Hisada M, Galvão-Castro B, Asquith B, McVicar DW.
In Contrast to HIV, KIR3DS1 Does Not Influence Outcome In HTLV-1 Retroviral Infection.
Hum. Immunol. 73: 783-7, 2012.
[Journal]
6)  Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S.
Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis.
J. Immunol. 188: 5585-92, 2012.
[Journal]
7)  O'Connor GM, Yamada E, Rampersaud A, Thomas R, Carrington M, McVicar DW.
Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1.
J. Immunol. 187: 2162-71, 2011.
[Journal]
8)  Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, McVicar DW, Altfeld M.
Common HIV-1 Peptide Variants Mediate Differential Binding of KIR3DL1 to HLA-Bw4 Molecules.
J. Virol. 85: 5970-4, 2011.
[Journal]
9)  Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, Gras S, Saunders PM, Olshina MA, Widjaja JM, Harpur CM, Lin J, Maloveste SM, Price DA, Lafont BA, McVicar DW, Clements CS, Brooks AG, Rossjohn J.
Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.
Nature. 479: 401-5, 2011.
[Journal]
10)  Orr SJ, Roessler S, Quigley L, Chan T, Ford JW, O'Connor GM, McVicar DW.
Implications for gene therapy-limiting expression of IL-2Rgammac delineate differences in signaling thresholds required for lymphocyte development and maintenance.
J. Immunol. 185: 1393-403, 2010.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/19/2014.